In the News

1857 News Items found
Person taking leftovers out of the refrigerator
Learn how people with cancer can protect themselves against foodborne illness.
GSK dean and graduates in their caps and gowns
Event
At Memorial Sloan Kettering Cancer Center’s 43rd annual event recognizing graduates and award winners, honorees were welcomed back to an in-person event.
Tomya Watt
Tomya Watt, Chief Diversity Officer and Vice President of Talent Acquisition and Mobility, was selected to receive the 2022 Moves Mentor Award from ’Moves‘ Magazine.
A woman's torso, arms, and hands are shown. She is holding a smart phone.
Finding
Despite the promise of eventually using artificial intelligence to detect melanoma, much more research and development are needed, MSK experts find.
Memorial Sloan Kettering physician-scientist Vinod Balachandran, who specializes in treating pancreatic cancer
Research confirms a sound strategy for designing a therapeutic vaccine for pancreatic cancer.
MSK scientists Andrew Kung and Elli Papaemmanuil
By sequencing the entire genome of a tumor, the experimental test will go beyond standard testing for common cancers in adults.
Richard Gilbertson, MBBS, PhD
Memorial Sloan Kettering Cancer Center (MSK) announced that pediatric oncologist Richard Gilbertson, MBBS, PhD, of Cancer Research UK Cambridge Institute, has been named the 2022 recipient of The Society of Memorial Sloan Kettering Prize.
Mary Wu
Mary Wu: A Champion for Life
Meet Mary Wu, a patient financial services specialist at Memorial Sloan Kettering Westchester.
Gerstner Sloan Kettering Students
Eight scientists are poised to receive their doctorates and embark on careers tackling problems in human disease through biomedical research. Their years of dedication and training will be recognized on May 18, 2022, when they will be awarded their PhD degrees from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK). This year’s commencement marks the school’s 11th graduating class since admitting its first students in 2006.
MSK medical oncologist Marjorie Zauderer, who specializes in treating mesotheliomas
A targeted drug shows promise for controlling pleural mesothelioma.